ARCHIVES

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

Von Eschenbach says oncology is undergoing a “revolutionary evolution.”

May 20, 2005

Leukemia Society Accepting Grant Applications for ‘88

May 22, 1987

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

November 23, 1979

NCAB Meeting Moved To October

July 20, 1979

Cooperative Group Chairman Blast Cut In’81 Budget

February 15, 1980

DRCCA Board Approves CCOP, Limited Recompetition Of Cooperative Group Program, New Control Efforts

October 30, 1981